1 Destination India: Contract Research in Pharmaceuticals & Healthcare S.P. Vasireddi, Ph.D Chairman, ACRO 26/03/2009.

Slides:



Advertisements
Similar presentations
Ferring Controlled Therapeutics
Advertisements

Dec.11, 2008 Raymond James Boston Fall Investors Conference Boston, Massachusetts.
Integrative Organs Systems Scientists and Drug Discovery: The Link Between Big Pharma and Academia Glenn A. Reinhart, Ph.D. Senior Group Leader Integrative.
Exploring ways to Make INDIA –A hub for Clinical Research.
US Pharmaceutical/Medical Device Regulatory and Product Development Overview Tom Gardner.
Establishing Preclinical Development Operations in China Ming Guo, Ph.D. VP Pharmaceutical Sciences & Manufacturing SABPA Pacific Forum Nov. 4, 2006.
PARMEE DEDHIA M.Pharm (Clinical Pharmacy), NMIMS
Stefan Franzén Introduction to clinical trials.
+ Drug Development and Review Process. + Objectives Learn the processes involved in drug discovery and development Define the phases involved in FDA drug.
Career Opportunities for PharmDs in the Pharmaceutical Industry: Research & Development.
NMF 3/6/03 Susan Galbraith, MB BChir PhD Vice President Clinical Discovery Oncology & Immunology Phase 0 Trials Why aren’t they more widely used by industry?
1 ICON plc Investor Update March Certain statements contained herein including, without limitation, statements containing.
National University of Singapore Department of Pharmacy 21 Nov 2006 KPP Prasad, Ph.D. Quality Operations Director Pfizer Global Manufacturing The Pharmaceutical.
“SHOW CASING A.P.” FAPCCI Seminar on “Meeting Global Outsourcing Requirement” PRESENTATION By DR.P.V.APPAJI M.Pharm, Ph.D EXECUTIVE DIRECTOR PHARMEXCIL.
Stages of drug development
Company Confidential Outsourcing Trends & Data.
Hale & Tempest India Biotech Briefing Dr. Brian W Tempest IBIZ Conference, NHS Expo Excel London UK 9 March 2011.
Eureka Pre-Clinical Investigation Animal toxicology Animal pharmacokinetics/ pharmacodynamics Clinical Investigation Phase I Safety and pharmacology Phase.
Obtaining and Negotiatiing a Position in Industry/Biotech Roy G. Smith Ph.D. Director, Huffington Center on Aging Professor, Department of Molecular and.
Figure 4.1 NEW PRODUCT DEVELOPMENT PROCESS Finance Corporate strategy and portfolio decisions Regulatory affairs Marketing and sales + market research.
19/08/2007 KLE University, Belgaum, India1 REGULATORY GUIDELINES FOR PRECLINICAL AND CLINICAL VALIDATION OF TRADITIONAL MEDICINES Dr. Basavaraj K. Nanjwade.
Prof K M Prasanna Kumar Sr prof & Head-Endocrinology & Diabetes M S Ramaiah Medical college.
Stefan Franzén Introduction to clinical trials.
1 32nd WHO South-East Asia Advisory Committee on Health Research Bangkok, Thailand, October 2011 Review of work carried out by Subcommittee on Vaccines.
DRUG DEVELOPMENT & REGULATIONS DR ARIF HASHMI. DRUG DEVELOPMENT Discovery and synthesis Preclinical development (chemical testing, biological testing,
Business Value of SW in Drug Discovery Eric Neumann, W3C HCLSIG co-chair Teranode Corporation F2F Cambridge MA.
Hale & Tempest India UKIBC Briefing Dr. Brian W Tempest UK India Business Council Manchester 10 March 2011.
Global Recognition of the Indian Biotech Sector - The Road Ahead Sept 26,2003 Hyderabad.
HERBALS IN PHARMACY: CHALLENGES Zhari Ismail PhD (U of Strathclyde) Pharmaceutical Chemistry Discipline School of Pharmaceutical Sciences Universiti Sains.
April 2005 How Patients Can Benefit From Molecular Imaging Paula M. Jacobs, Ph.D Vice President Advanced Magnetics, Inc.
Chairman’s Welcome & Opening Remarks Mumbai, India – 24 th July 2007.
The FDA: Basic Facts It takes 12 to 15 years to develop a single drug Only 1 in 10,000 potential medications makes it completely through the process Only.
ISPE Central Canada Chapter Annual Meeting September 28, 2006 Yvon R. Tessier Pharmaceutical contract manufacturing challenges.
Privacy Symposium / HIPAA Summit
Career opportunities in medical research. Basic research.
European Patients’ Academy on Therapeutic Innovation The key principles of pharmacology.
ARRRR! Drug Development and Discovery Access to Essential Medicines De-Cal Fall Week 2.
Lartigau Oriane Polin Nicolas 5th year of Pharmacy-Industrial course 2014, February.
Unprecedented Growth & Future Job Opportunity BIOTECHNOLOGY Dr. Sanjiv Kumar Maheshwari Professor and Dean, IFTM University, Moradabad.
India a Shining example.... Yunus Bukhari
Pharmaceutical Industry R&D An inside-out look at trends and career opportunities  Lots of promise but little delivered in the way of new drugs  Vastly.
Division of Cancer Treatment and Diagnosis Presented By: Michael Difilippantonio, Ph.D. October 1, 2015.
1 Promotion in Management and Research Tracks in Industry Magdalena Alonso-Galicia, PhD Cardiovascular Diseases Department Merck Research Laboratories.
Market Data Industry Outlook & Requirements. Copyright © IT Sector Growth (Revenue) Trend IMS is emerging as a key growth driver.
Inventions Research & Development (R&D) in Pharmaceuticals DISCOVERY Enzymes, receptors, & genetics, DEVELOPMENT Safety, quality and efficacy tests PRODUCTION.
© 2016 Global Market Insights, Inc. USA. All Rights Reserved Fuel Cell Market size worth $25.5bn by 2024 Pharmacovigilance Market Size,
© 2016 Global Market Insights, Inc. USA. All Rights Reserved CTMS Market share to reach $2bn by 2024.
© 2016 Global Market Insights, Inc. USA. All Rights Reserved U.S. Pharmacovigilance Market to grow at 10.7% CAGR from 2016 to 2024.
© 2016 Global Market Insights, Inc. USA. All Rights Reserved Bioreactor Market to reach $1.9 billion by 2024.
© 2016 Global Market Insights, Inc. USA. All Rights Reserved Gene Editing Market to grow at 14% CAGR from 2016 to 2024
© 2016 Global Market Insights, Inc. USA. All Rights Reserved Fuel Cell Market size worth $25.5bn by 2024 Clinical Trial Management System.
Drug Discovery &Development
CK707 BSc in Medical and Health Sciences
A journey through drug discovery The life cycle of a new medicine
Biosimulation Market by Product & Application
U.S. Healthcare Artificial Intelligence Market to grow at 38% CAGR from 2017 to 2024
Pharmacovigilance Market Application Development, Price Trends, Forecast by 2017 – 2024
Precision Medicine Market to witness more than 10.5% CAGR from 2017 to 2024
Regulatory Perspective
IDSC From Hit to the Clinic… Your Drug Discovery & Development Partner
Pharmacist- Career Opportunities
Databridgemarketresearch.comdatabridgemarketresearch.com US : UK :
Innovation & the Pharmaceutical Research & Development Industry
STRENGTH BY NUMBERS.
IDSC From Hit to the Clinic…Your Drug Discovery & Development Partner
Syllabus Chapter Heads
IDSC From Hit to the Clinic…Your Drug Discovery & Development Partner
Small Animal Imaging Market Global Industry Analysis, Size & Growth
Fillers in the Global Pharmaceutical Market Report : Trends, Forecast and Competitive Analysis 1.
The global e-clinical solution software market is expected to grow at a CAGR of 13.8% during the forecast period, 2019–2026.
Presentation transcript:

1 Destination India: Contract Research in Pharmaceuticals & Healthcare S.P. Vasireddi, Ph.D Chairman, ACRO 26/03/2009

2 Industrial Research & Outsourcing to India

3 India scores high on location attractiveness & work capabilities: Realized by IT a decade back, true for Pharma, as well.

4 Industrial Research & Outsourcing to India Quality, Productivity at a lower cost still stands true for Pharma outsourcing

5 Research in Pharmaceutical Industry 1. CMC Research: Analytical Chemistry, Pharmaceutical Chemistry, Stability studies, Medicinal Chemistry etc.; 2. Preclinical Research: Lab. Animal studies- Pharmacology, Toxicology, Pharmacokinetics (Pk); 3. Clinical Research: Phase 0-4, Clinical Efficacy and Safety studies, Clinical Pk Studies including BA/BE studies; 4. Marketing Research: Market positioning, Market dynamics, Competitors etc.; 5. Supportive Research: Clinical Reference Labs, Pharmacovigilance Research, Advanced molecular biology, Clinical Data and Image Processing.

6 Research in Pharmaceutical Industry

7 Contract Research vs Contract Clinical Research Clinical

8 Contract Clinical Research in India Global Pharma R & D cost : 60 bn USD Global clinical trial market : bn USD Industry stretch estimate bn USD by 2010 in India – Source :Mckinsey Report India poised to capture 10% global Clinical Trials market by 2010 – E & Y Survey Costs of Trials>50%lower Vs US GlobalIndia World Pharma:~ 427 Billion ~ $7 Billion Clinical Research:~ Billion ~ 600 Million (Potential >$1-1.5 Bn 2010) ( ) Total Outsourced: ~ 12.5 Billion Big Opportunity No. of CROs: ~ 800 – 1,000>

9 Contract Clinical Research in India

10 Outsourcing To India